GB2451769A — An interactive auto-injector
Assigned to Intelliject Inc · Expires 2009-02-11 · 17y expired
What this patent protects
An auto-injector provides a user with visual, haptic, and/or audible feedback in order to allow for easy injection of medications. The audible feedback may be in the form of a pre-recorded voice giving the user information on how to operate the device, details of dosage arrangeme…
USPTO Abstract
An auto-injector provides a user with visual, haptic, and/or audible feedback in order to allow for easy injection of medications. The audible feedback may be in the form of a pre-recorded voice giving the user information on how to operate the device, details of dosage arrangements, or relevant safety information. The injector can comprise an information device and/or system comprising at least one sensor, a switch, a processing unit, and an electronic output system. The electronic circuit system may be incorporated into a label which is affixed to the housing of the device.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.